APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injectable Ketamine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Injectable Ketamine Industry Growth and Trends Forecast to 2032

26 December 2025105 pages

Choose your research edition.

Industry ResearchInjectable Ketamine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Ketamine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Injectable Ketamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Ketamine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Ketamine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Injectable Ketamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injectable Ketamine include Anhui Wanhe Pharmaceutical, Pfizer, Hengrui, Troikaa Parenterals, Taj Pharmaceuticals, Supriya Lifesciences, Sun Pharmaceuticals, Seqens and Samarth Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Injectable Ketamine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Injectable Ketamine market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Injectable Ketamine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Injectable Ketamine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Injectable Ketamine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Injectable Ketamine Market by Company

Anhui Wanhe Pharmaceutical

Pfizer

Hengrui

Troikaa Parenterals

Taj Pharmaceuticals

Supriya Lifesciences

Sun Pharmaceuticals

Seqens

Samarth Pharma

Neon Laboratories

Ketalar

Hameln Pharma ltd

Greenco Biologicals

BNM Organics

Injectable Ketamine Segment by Type

Standard Ketamine

Low-Dose Ketamine

High-Dose Ketamine

Injectable Ketamine Segment by Application

Mental Health Treatment

Pain Management

Anesthetic Use

Injectable Ketamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Ketamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Ketamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Ketamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Ketamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Injectable Ketamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Standard Ketamine Table 2. Major Company of Low-Dose Ketamine Table 3. Major Company of High-Dose Ketamine Table 4. Global Injectable Ketamine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Injectable Ketamine Sales by Type (2021-2026) & (Kg) Table 6. Global Injectable Ketamine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Injectable Ketamine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Injectable Ketamine Sales Market Share in Value by Type (2021-2026) Table 9. Global Injectable Ketamine Price by Type (2021-2026) & (US$/g) Table 10. Global Injectable Ketamine Sales by Type (2027-2032) & (Kg) Table 11. Global Injectable Ketamine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Injectable Ketamine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Injectable Ketamine Sales Market Share in Value by Type (2027-2032) Table 14. Global Injectable Ketamine Price by Type (2027-2032) & (US$/g) Table 15. North America Injectable Ketamine Sales by Type (2021-2026) & (Kg) Table 16. North America Injectable Ketamine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Injectable Ketamine Sales by Type (2021-2026) & (Kg) Table 18. Europe Injectable Ketamine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Injectable Ketamine Sales by Type (2021-2026) & (Kg) Table 20. Asia-Pacific Injectable Ketamine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Injectable Ketamine Sales by Type (2021-2026) & (Kg) Table 22. Latin America Injectable Ketamine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Injectable Ketamine Sales by Type (2021-2026) & (Kg) Table 24. Middle East and Africa Injectable Ketamine Sales by Type (2021-2026) & (US$ Million) Table 25. Injectable Ketamine Industry Trends Table 26. Injectable Ketamine Industry Drivers Table 27. Injectable Ketamine Industry Opportunities and Challenges Table 28. Injectable Ketamine Industry Restraints Table 29. Global Injectable Ketamine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Injectable Ketamine Revenue Market Share by Company (2021-2026) Table 31. Global Injectable Ketamine Sales by Company (2021-2026) & (Kg) Table 32. Global Injectable Ketamine Sales Share by Company (2021-2026) Table 33. Global Injectable Ketamine Market Price by Company (2021-2026) & (US$/g) Table 34. Global Injectable Ketamine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Injectable Ketamine Major Company Production Sites and Headquarters Table 36. Global Injectable Ketamine Company, Product Type & Application Table 37. Global Injectable Ketamine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Injectable Ketamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Injectable Ketamine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Injectable Ketamine Sales by Region (2021-2026) & (Kg) Table 42. Global Injectable Ketamine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Injectable Ketamine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Injectable Ketamine Sales Market Share in Value by Region (2021-2026) Table 45. Global Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 46. Global Injectable Ketamine Sales by Region (2027-2032) & (Kg) Table 47. Global Injectable Ketamine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Injectable Ketamine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Injectable Ketamine Sales Market Share in Value by Region (2027-2032) Table 50. Global Injectable Ketamine Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 51. Global Injectable Ketamine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Injectable Ketamine Sales by Application (2021-2026) & (Kg) Table 53. Global Injectable Ketamine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Injectable Ketamine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Injectable Ketamine Sales Market Share in Value by Application (2021-2026) Table 56. Global Injectable Ketamine Price by Application (2021-2026) & (US$/g) Table 57. Global Injectable Ketamine Sales by Application (2027-2032) & (Kg) Table 58. Global Injectable Ketamine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Injectable Ketamine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Injectable Ketamine Sales Market Share in Value by Application (2027-2032) Table 61. Global Injectable Ketamine Price by Application (2027-2032) & (US$/g) Table 62. North America Injectable Ketamine Sales by Application (2021-2026) & (Kg) Table 63. North America Injectable Ketamine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Injectable Ketamine Sales by Application (2021-2026) & (Kg) Table 65. Europe Injectable Ketamine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Injectable Ketamine Sales by Application (2021-2026) & (Kg) Table 67. Asia-Pacific Injectable Ketamine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Injectable Ketamine Sales by Application (2021-2026) & (Kg) Table 69. Latin America Injectable Ketamine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Injectable Ketamine Sales by Application (2021-2026) & (Kg) Table 71. Middle East and Africa Injectable Ketamine Sales by Application (2021-2026) & (US$ Million) Table 72. Anhui Wanhe Pharmaceutical Company Information Table 73. Anhui Wanhe Pharmaceutical Business Overview Table 74. Anhui Wanhe Pharmaceutical Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 75. Anhui Wanhe Pharmaceutical Injectable Ketamine Product Portfolio Table 76. Anhui Wanhe Pharmaceutical Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 80. Pfizer Injectable Ketamine Product Portfolio Table 81. Pfizer Recent Development Table 82. Hengrui Company Information Table 83. Hengrui Business Overview Table 84. Hengrui Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 85. Hengrui Injectable Ketamine Product Portfolio Table 86. Hengrui Recent Development Table 87. Troikaa Parenterals Company Information Table 88. Troikaa Parenterals Business Overview Table 89. Troikaa Parenterals Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 90. Troikaa Parenterals Injectable Ketamine Product Portfolio Table 91. Troikaa Parenterals Recent Development Table 92. Taj Pharmaceuticals Company Information Table 93. Taj Pharmaceuticals Business Overview Table 94. Taj Pharmaceuticals Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 95. Taj Pharmaceuticals Injectable Ketamine Product Portfolio Table 96. Taj Pharmaceuticals Recent Development Table 97. Supriya Lifesciences Company Information Table 98. Supriya Lifesciences Business Overview Table 99. Supriya Lifesciences Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 100. Supriya Lifesciences Injectable Ketamine Product Portfolio Table 101. Supriya Lifesciences Recent Development Table 102. Sun Pharmaceuticals Company Information Table 103. Sun Pharmaceuticals Business Overview Table 104. Sun Pharmaceuticals Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 105. Sun Pharmaceuticals Injectable Ketamine Product Portfolio Table 106. Sun Pharmaceuticals Recent Development Table 107. Seqens Company Information Table 108. Seqens Business Overview Table 109. Seqens Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 110. Seqens Injectable Ketamine Product Portfolio Table 111. Seqens Recent Development Table 112. Samarth Pharma Company Information Table 113. Samarth Pharma Business Overview Table 114. Samarth Pharma Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 115. Samarth Pharma Injectable Ketamine Product Portfolio Table 116. Samarth Pharma Recent Development Table 117. Neon Laboratories Company Information Table 118. Neon Laboratories Business Overview Table 119. Neon Laboratories Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 120. Neon Laboratories Injectable Ketamine Product Portfolio Table 121. Neon Laboratories Recent Development Table 122. Ketalar Company Information Table 123. Ketalar Business Overview Table 124. Ketalar Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 125. Ketalar Injectable Ketamine Product Portfolio Table 126. Ketalar Recent Development Table 127. Hameln Pharma ltd Company Information Table 128. Hameln Pharma ltd Business Overview Table 129. Hameln Pharma ltd Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 130. Hameln Pharma ltd Injectable Ketamine Product Portfolio Table 131. Hameln Pharma ltd Recent Development Table 132. Greenco Biologicals Company Information Table 133. Greenco Biologicals Business Overview Table 134. Greenco Biologicals Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 135. Greenco Biologicals Injectable Ketamine Product Portfolio Table 136. Greenco Biologicals Recent Development Table 137. BNM Organics Company Information Table 138. BNM Organics Business Overview Table 139. BNM Organics Injectable Ketamine Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 140. BNM Organics Injectable Ketamine Product Portfolio Table 141. BNM Organics Recent Development Table 142. North America Injectable Ketamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 143. North America Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 144. North America Injectable Ketamine Sales Market Share by Country (2021-2026) Table 145. North America Injectable Ketamine Sales Forecast by Country (2027-2032) & (Kg) Table 146. North America Injectable Ketamine Sales Market Share Forecast by Country (2027-2032) Table 147. North America Injectable Ketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Injectable Ketamine Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Injectable Ketamine Market Share by Country (2021-2026) Table 150. North America Injectable Ketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Injectable Ketamine Market Share Forecast by Country (2027-2032) Table 152. Europe Injectable Ketamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 153. Europe Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 154. Europe Injectable Ketamine Sales Market Share by Country (2021-2026) Table 155. Europe Injectable Ketamine Sales Forecast by Country (2027-2032) & (Kg) Table 156. Europe Injectable Ketamine Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Injectable Ketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Injectable Ketamine Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Injectable Ketamine Market Share by Country (2021-2026) Table 160. Europe Injectable Ketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Injectable Ketamine Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Injectable Ketamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 164. Asia-Pacific Injectable Ketamine Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Injectable Ketamine Sales Forecast by Country (2027-2032) & (Kg) Table 166. Asia-Pacific Injectable Ketamine Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Injectable Ketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Injectable Ketamine Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Injectable Ketamine Market Share by Country (2021-2026) Table 170. Asia-Pacific Injectable Ketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Injectable Ketamine Market Share Forecast by Country (2027-2032) Table 172. Latin America Injectable Ketamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 173. Latin America Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 174. Latin America Injectable Ketamine Sales Market Share by Country (2021-2026) Table 175. Latin America Injectable Ketamine Sales Forecast by Country (2027-2032) & (Kg) Table 176. Latin America Injectable Ketamine Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Injectable Ketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Injectable Ketamine Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Injectable Ketamine Market Share by Country (2021-2026) Table 180. Latin America Injectable Ketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Injectable Ketamine Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Injectable Ketamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 184. Middle East and Africa Injectable Ketamine Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Injectable Ketamine Sales Forecast by Country (2027-2032) & (Kg) Table 186. Middle East and Africa Injectable Ketamine Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Injectable Ketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Injectable Ketamine Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Injectable Ketamine Market Share by Country (2021-2026) Table 190. Middle East and Africa Injectable Ketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Injectable Ketamine Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Injectable Ketamine Distributors List Table 195. Injectable Ketamine Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Injectable Ketamine Image Figure 2. Global Injectable Ketamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Ketamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Injectable Ketamine Sales (2021-2032) & (Kg) Figure 5. Standard Ketamine Image Figure 6. Global Standard Ketamine Sales YoY Growth (2021-2032) & (Kg) Figure 7. Low-Dose Ketamine Image Figure 8. Global Low-Dose Ketamine Sales YoY Growth (2021-2032) & (Kg) Figure 9. High-Dose Ketamine Image Figure 10. Global High-Dose Ketamine Sales YoY Growth (2021-2032) & (Kg) Figure 11. Global Injectable Ketamine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Injectable Ketamine Market Share by Type 2025 VS 2032 Figure 13. North America Injectable Ketamine Sales Market Share in Volume by Type in 2025 Figure 14. North America Injectable Ketamine Sales Market Share in Value by Type in 2025 Figure 15. Europe Injectable Ketamine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Injectable Ketamine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Injectable Ketamine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Injectable Ketamine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Injectable Ketamine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Injectable Ketamine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Injectable Ketamine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Injectable Ketamine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Injectable Ketamine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Mental Health Treatment Image Figure 26. Global Mental Health Treatment Sales YoY Growth (2021-2032) & (Kg) Figure 27. Pain Management Image Figure 28. Global Pain Management Sales YoY Growth (2021-2032) & (Kg) Figure 29. Anesthetic Use Image Figure 30. Global Anesthetic Use Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Injectable Ketamine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Injectable Ketamine Market Share by Application 2025 VS 2032 Figure 33. North America Injectable Ketamine Sales Market Share in Volume by Application in 2025 Figure 34. North America Injectable Ketamine Sales Market Share in Value by Application in 2025 Figure 35. Europe Injectable Ketamine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Injectable Ketamine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Injectable Ketamine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Injectable Ketamine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Injectable Ketamine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Injectable Ketamine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Injectable Ketamine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Injectable Ketamine Sales Market Share in Value by Application in 2025 Figure 43. North America Injectable Ketamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Injectable Ketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Injectable Ketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Injectable Ketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Injectable Ketamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Injectable Ketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Injectable Ketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Injectable Ketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Injectable Ketamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Injectable Ketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Injectable Ketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Injectable Ketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Injectable Ketamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Injectable Ketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Injectable Ketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Injectable Ketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Injectable Ketamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Injectable Ketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Injectable Ketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Injectable Ketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Injectable Ketamine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Injectable Ketamine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Standard Ketamine
  • Low-Dose Ketamine
  • High-Dose Ketamine
Applications
  • Mental Health Treatment
  • Pain Management
  • Anesthetic Use
Companies covered
  • Anhui Wanhe Pharmaceutical
  • Pfizer
  • Hengrui
  • Troikaa Parenterals
  • Taj Pharmaceuticals
  • Supriya Lifesciences
  • Sun Pharmaceuticals
  • Seqens
  • Samarth Pharma
  • Neon Laboratories
  • Ketalar
  • Hameln Pharma ltd
  • Greenco Biologicals
  • BNM Organics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Injectable Ketamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Injectable Ketamine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Injectable Ketamine Market by Type
  6. 1.3.1 Standard Ketamine
  7. 1.3.2 Low-Dose Ketamine
  8. 1.3.3 High-Dose Ketamine
  9. 1.4 Global Injectable Ketamine Market Size by Type
  10. 1.4.1 Global Injectable Ketamine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Injectable Ketamine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Injectable Ketamine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Injectable Ketamine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Injectable Ketamine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Injectable Ketamine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Injectable Ketamine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Injectable Ketamine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Injectable Ketamine Industry Trends
  2. 2.2 Injectable Ketamine Industry Drivers
  3. 2.3 Injectable Ketamine Industry Opportunities and Challenges
  4. 2.4 Injectable Ketamine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Injectable Ketamine Revenue (2021-2026)
  2. 3.2 Global Top Players by Injectable Ketamine Sales (2021-2026)
  3. 3.3 Global Top Players by Injectable Ketamine Price (2021-2026)
  4. 3.4 Global Injectable Ketamine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injectable Ketamine Major Company Production Sites & Headquarters
  6. 3.6 Global Injectable Ketamine Company, Product Type & Application
  7. 3.7 Global Injectable Ketamine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injectable Ketamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injectable Ketamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injectable Ketamine Tier 1, Tier 2, and Tier 3
4 Injectable Ketamine Regional Status and Outlook
  1. 4.1 Global Injectable Ketamine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Injectable Ketamine Historic Market Size by Region
  3. 4.2.1 Global Injectable Ketamine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Injectable Ketamine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Injectable Ketamine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Injectable Ketamine Forecasted Market Size by Region
  7. 4.3.1 Global Injectable Ketamine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Injectable Ketamine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Injectable Ketamine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Injectable Ketamine by Application
  1. 5.1 Injectable Ketamine Market by Application
  2. 5.1.1 Mental Health Treatment
  3. 5.1.2 Pain Management
  4. 5.1.3 Anesthetic Use
  5. 5.2 Global Injectable Ketamine Market Size by Application
  6. 5.2.1 Global Injectable Ketamine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Injectable Ketamine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Injectable Ketamine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Injectable Ketamine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Injectable Ketamine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Injectable Ketamine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Injectable Ketamine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Injectable Ketamine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Anhui Wanhe Pharmaceutical
  2. 6.1.1 Anhui Wanhe Pharmaceutical Company Information
  3. 6.1.2 Anhui Wanhe Pharmaceutical Business Overview
  4. 6.1.3 Anhui Wanhe Pharmaceutical Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Anhui Wanhe Pharmaceutical Injectable Ketamine Product Portfolio
  6. 6.1.5 Anhui Wanhe Pharmaceutical Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Injectable Ketamine Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Hengrui
  14. 6.3.1 Hengrui Company Information
  15. 6.3.2 Hengrui Business Overview
  16. 6.3.3 Hengrui Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hengrui Injectable Ketamine Product Portfolio
  18. 6.3.5 Hengrui Recent Developments
  19. 6.4 Troikaa Parenterals
  20. 6.4.1 Troikaa Parenterals Company Information
  21. 6.4.2 Troikaa Parenterals Business Overview
  22. 6.4.3 Troikaa Parenterals Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Troikaa Parenterals Injectable Ketamine Product Portfolio
  24. 6.4.5 Troikaa Parenterals Recent Developments
  25. 6.5 Taj Pharmaceuticals
  26. 6.5.1 Taj Pharmaceuticals Company Information
  27. 6.5.2 Taj Pharmaceuticals Business Overview
  28. 6.5.3 Taj Pharmaceuticals Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Taj Pharmaceuticals Injectable Ketamine Product Portfolio
  30. 6.5.5 Taj Pharmaceuticals Recent Developments
  31. 6.6 Supriya Lifesciences
  32. 6.6.1 Supriya Lifesciences Company Information
  33. 6.6.2 Supriya Lifesciences Business Overview
  34. 6.6.3 Supriya Lifesciences Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Supriya Lifesciences Injectable Ketamine Product Portfolio
  36. 6.6.5 Supriya Lifesciences Recent Developments
  37. 6.7 Sun Pharmaceuticals
  38. 6.7.1 Sun Pharmaceuticals Company Information
  39. 6.7.2 Sun Pharmaceuticals Business Overview
  40. 6.7.3 Sun Pharmaceuticals Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sun Pharmaceuticals Injectable Ketamine Product Portfolio
  42. 6.7.5 Sun Pharmaceuticals Recent Developments
  43. 6.8 Seqens
  44. 6.8.1 Seqens Company Information
  45. 6.8.2 Seqens Business Overview
  46. 6.8.3 Seqens Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Seqens Injectable Ketamine Product Portfolio
  48. 6.8.5 Seqens Recent Developments
  49. 6.9 Samarth Pharma
  50. 6.9.1 Samarth Pharma Company Information
  51. 6.9.2 Samarth Pharma Business Overview
  52. 6.9.3 Samarth Pharma Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Samarth Pharma Injectable Ketamine Product Portfolio
  54. 6.9.5 Samarth Pharma Recent Developments
  55. 6.10 Neon Laboratories
  56. 6.10.1 Neon Laboratories Company Information
  57. 6.10.2 Neon Laboratories Business Overview
  58. 6.10.3 Neon Laboratories Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Neon Laboratories Injectable Ketamine Product Portfolio
  60. 6.10.5 Neon Laboratories Recent Developments
  61. 6.11 Ketalar
  62. 6.11.1 Ketalar Company Information
  63. 6.11.2 Ketalar Business Overview
  64. 6.11.3 Ketalar Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Ketalar Injectable Ketamine Product Portfolio
  66. 6.11.5 Ketalar Recent Developments
  67. 6.12 Hameln Pharma ltd
  68. 6.12.1 Hameln Pharma ltd Company Information
  69. 6.12.2 Hameln Pharma ltd Business Overview
  70. 6.12.3 Hameln Pharma ltd Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hameln Pharma ltd Injectable Ketamine Product Portfolio
  72. 6.12.5 Hameln Pharma ltd Recent Developments
  73. 6.13 Greenco Biologicals
  74. 6.13.1 Greenco Biologicals Company Information
  75. 6.13.2 Greenco Biologicals Business Overview
  76. 6.13.3 Greenco Biologicals Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Greenco Biologicals Injectable Ketamine Product Portfolio
  78. 6.13.5 Greenco Biologicals Recent Developments
  79. 6.14 BNM Organics
  80. 6.14.1 BNM Organics Company Information
  81. 6.14.2 BNM Organics Business Overview
  82. 6.14.3 BNM Organics Injectable Ketamine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 BNM Organics Injectable Ketamine Product Portfolio
  84. 6.14.5 BNM Organics Recent Developments
7 North America by Country
  1. 7.1 North America Injectable Ketamine Sales by Country
  2. 7.1.1 North America Injectable Ketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Injectable Ketamine Sales by Country (2021-2026)
  4. 7.1.3 North America Injectable Ketamine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Injectable Ketamine Market Size by Country
  6. 7.2.1 North America Injectable Ketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Injectable Ketamine Market Size by Country (2021-2026)
  8. 7.2.3 North America Injectable Ketamine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Injectable Ketamine Sales by Country
  2. 8.1.1 Europe Injectable Ketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Injectable Ketamine Sales by Country (2021-2026)
  4. 8.1.3 Europe Injectable Ketamine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Injectable Ketamine Market Size by Country
  6. 8.2.1 Europe Injectable Ketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Injectable Ketamine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Injectable Ketamine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Injectable Ketamine Sales by Country
  2. 9.1.1 Asia-Pacific Injectable Ketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Injectable Ketamine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Injectable Ketamine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Injectable Ketamine Market Size by Country
  6. 9.2.1 Asia-Pacific Injectable Ketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Injectable Ketamine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Injectable Ketamine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Injectable Ketamine Sales by Country
  2. 10.1.1 South America Injectable Ketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Injectable Ketamine Sales by Country (2021-2026)
  4. 10.1.3 South America Injectable Ketamine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Injectable Ketamine Market Size by Country
  6. 10.2.1 South America Injectable Ketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Injectable Ketamine Market Size by Country (2021-2026)
  8. 10.2.3 South America Injectable Ketamine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Injectable Ketamine Sales by Country
  2. 11.1.1 Middle East and Africa Injectable Ketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Injectable Ketamine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Injectable Ketamine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Injectable Ketamine Market Size by Country
  6. 11.2.1 Middle East and Africa Injectable Ketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Injectable Ketamine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Injectable Ketamine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Injectable Ketamine Value Chain Analysis
  2. 12.1.1 Injectable Ketamine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Injectable Ketamine Production Mode & Process
  7. 12.2 Injectable Ketamine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Injectable Ketamine Distributors
  10. 12.2.3 Injectable Ketamine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst